33882

33882
Filippatos G, Anker SD, Butler J, et al. Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: A secondary analysis of EMPEROR-Reduced. Eur J Heart Fail 2022; 24(12):2297–304. DOI: 10.1002/ejhf.2707. http://www.ncbi.nlm.nih.gov/pubmed/36194680
Einstellungen
33882
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 29.11.2023 | 10:39 Uhr